India's ban on e-cigarettes and heated tobacco under scrutiny

Dec.08.2022
India's ban on e-cigarettes and heated tobacco under scrutiny
India bans e-cigarettes and heated tobacco products, but experts argue the policy is ineffective and harms consumers.

On December 2, 2019, the upper house of India's parliament approved a ban on e-cigarettes and heated tobacco products citing the World Health Organization's guidelines about the threat posed to young people.


Three years later, consumer advocates and experts in reducing tobacco harm state that the ban has been ineffective, as no safety checks or measures to combat the black market have been implemented, resulting in even greater harm.


According to public health expert and former director of the UK anti-smoking organization Action on Smoking and Health (ASH), Clive Bates, "From a large body of research, we know that electronic cigarettes are far less harmful than smoking and are replacing combustible tobacco. Therefore, allowing the sale of deadly cigarettes while banning electronic cigarettes is a ridiculous policy.


Bates presented information during a webinar organized by the Association of Vapers India (AVI), a non-profit consumer organization representing the interests of 270 million tobacco users in the country.


Jagannath Sarangapani, a member of the AVI that organized the event, said, "This ban has had a negative impact on over 100 million smokers in India, depriving them of their basic rights to health, choice, and a good life.


A web seminar titled "The Necessity of Developing Countries to Reduce Tobacco Harm" was held, with speakers and panel members from around the world, including Asia, Africa, and Latin America where 80% of tobacco users reside.


Every smoker is different and they need all available options to quit smoking. Taking away any one option would harm people and result in deaths," said Charles Gardner, Executive Director of INNCO, an organization made up of consumer groups from 37 countries, and former health commissioner at the U.S. embassy in India.


Peter Dator, of the Philippine consumer organization, stated that this decision could potentially reduce the country's smoking rate and could serve as a model for other developing countries. The regulation provides controlled access for adult smokers while also protecting minors. The law distinguishes between smoking and safer nicotine products.


Dr. Jasjit Ahluwalia, a public health scientist at Brown University in the United States, expressed regret about India's lack of safer nicotine alternatives. "Reducing harm is a well-established concept, but we have not accepted alternative products in tobacco control because we dislike the industry so much that we have forgotten about smokers," he said. Learning that India has banned nicotine alternatives and even research on alternative products, he feels upset. "This is tragic. Science should provide information for policy.


The main author of the "Global State of Tobacco Harm Reduction" report, Harry Shapiro, has raised doubts about the Indian government's justification for the "Protecting Youth" ban. According to Shapiro, "India's latest global youth tobacco survey data reveals that 7 million schoolchildren used cigarettes in the past 30 days, and 3,000 used e-cigarettes. Therefore, this ban is more about money and politics than public health.


Many speakers also emphasized the role played by organizations sponsored by the WHO and Bloomberg in promoting the ban of new nicotine products in developing countries. Joseph Magero, a former tobacco control advocate in Kenya, stated that the WHO's ideological approach had been unsuccessful.


History has shown us time and time again that prohibition does not work. Prohibiting alcohol has led to an illegal market. Banning these products not only fails to achieve public health goals, but instead pushes them into unregulated and uncontrollable black markets," he remarked.


Physicist and director of a consumer non-profit organization, Roberto Sussman, has expressed support for e-cigarette users in India, stating that their situation is similar to ours due to government agencies spreading misinformation about e-cigarettes. However, we must continue to push back, despite bans on sales, as there is a black market for these products and people know that e-cigarettes can be a safer alternative.


Nancy Loucas, Executive Director of CAPHRA (Coalition of Asia-Pacific Tobacco Harm Reduction Advocates), shared some positive views and said, "There is reason to be optimistic. The harm reduction movement has begun in the East and is moving westward.


Starting from New Zealand, the trend of lifting bans on e-cigarettes is spreading to the Philippines, Indonesia and Malaysia. These countries are now also studying regulatory frameworks, while Thailand is also discussing reversing its ban on e-cigarettes. However, India needs to become the litmus test for a more comprehensive global transformation. With time, we will arrive there.


2FIRSTS will continue to provide ongoing coverage of this topic, with additional updates available on the '2FIRSTSAPP'. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11